MicroStrategy
MSTR
NVIDIA
NVDA
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
US Stock MarketDetailed Quotes
SYRA Syra Health
- 0.380
- +0.008+2.15%
Close Dec 20 16:00 ET
- 0.380
- 0.0000.00%
Post 20:01 ET
6.58MMarket Cap-1.51P/E (TTM)
0.410High0.371Low80.44KVolume0.388Open0.372Pre Close31.48KTurnover1.24%Turnover RatioLossP/E (Static)17.31MShares8.37052wk High1.98P/B2.47MFloat Cap0.34452wk Low--Dividend TTM6.49MShs Float8.370Historical High--Div YieldTTM10.48%Amplitude0.344Historical Low0.391Avg Price1Lot Size
Syra Health Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 42.49%2.25M | 101.14%1.97M | 47.46%1.75M | -1.83%5.52M | -10.15%1.77M | 4.45%1.58M | -17.89%979.25K | 25.71%1.19M | 298.43%5.62M | 1.97M |
| Operating revenue | 42.49%2.25M | 101.14%1.97M | 47.46%1.75M | -1.83%5.52M | -10.15%1.77M | 4.45%1.58M | -17.89%979.25K | 25.71%1.19M | 298.43%5.62M | --1.97M |
| Cost of revenue | 54.37%1.59M | 90.31%1.62M | 51.08%1.57M | -9.94%4.1M | -29.29%1.18M | -6.67%1.03M | -21.42%851.09K | 49.19%1.04M | 365.07%4.56M | 1.67M |
| Gross profit | 20.51%668.3K | 173.10%350.01K | 21.83%179.29K | 32.97%1.41M | 100.05%582.04K | 34.01%554.54K | 16.97%128.16K | -40.53%147.16K | 146.72%1.06M | 290.95K |
| Operating expense | 22.24%1.1M | 90.81%1.74M | 76.13%1.62M | 36.43%4.3M | 75.87%1.57M | 18.01%897.56K | 24.70%912.11K | 20.04%921.63K | 626.76%3.15M | 891.7K |
| Selling and administrative expenses | 17.13%1.04M | 60.60%1.45M | 46.52%1.33M | 29.02%4.01M | 49.97%1.31M | 17.74%885.2K | 23.12%899.82K | 18.56%909.87K | 646.59%3.11M | --875.13K |
| -Selling and marketing expense | ---- | 1,469.83%13.89K | 1,669.39%15.38K | ---- | ---- | ---- | --885 | --869 | ---- | ---- |
| -General and administrative expense | 17.13%1.04M | 59.21%1.43M | 44.97%1.32M | 29.02%4.01M | 49.97%1.31M | 17.74%885.2K | 23.00%898.94K | 18.45%909K | 646.59%3.11M | --875.13K |
| Research and development costs | --34.82K | --277.89K | --277.55K | --240.05K | --240.05K | --0 | --0 | --0 | --0 | ---- |
| Depreciation amortization depletion | 106.69%25.54K | 41.33%17.37K | 6.65%12.55K | 228.45%48.77K | 22.87%12.36K | 218.48%12.36K | 1,962.58%12.29K | 3,634.29%11.76K | 7,073.43%14.85K | --10.06K |
| -Depreciation and amortization | 106.69%25.54K | 41.33%17.37K | 6.65%12.55K | 228.45%48.77K | 22.87%12.36K | 218.48%12.36K | 1,962.58%12.29K | 3,634.29%11.76K | 7,073.43%14.85K | --10.06K |
| Other operating expenses | ---- | ---- | ---- | -89.04%3.37K | ---- | ---- | ---- | ---- | 76.47%30.74K | --6.51K |
| Operating profit | -25.04%-428.91K | -77.35%-1.39M | -86.44%-1.44M | -38.18%-2.89M | -64.15%-986.15K | 1.09%-343.02K | -26.06%-783.95K | -48.86%-774.48K | -63,610.21%-2.09M | -600.75K |
| Net non-operating interest income expense | 200.13%11.38K | 100.51%97 | 72.88%-3.1K | -78.24%-50.74K | 23.24%-9.12K | -46.69%-11.36K | -240.36%-18.85K | -245.34%-11.42K | -28.47K | -11.88K |
| Non-operating interest income | 383.72%13.64K | 95,550.00%3.83K | 48,950.00%981 | 4,569.84%2.94K | 1,188.89%116 | 7,957.14%2.82K | -78.95%4 | --2 | --63 | --9 |
| Non-operating interest expense | -84.02%2.27K | -80.22%3.73K | -64.30%4.08K | 88.15%53.69K | -22.33%9.24K | 82.29%14.18K | 239.27%18.85K | 245.40%11.42K | --28.53K | --11.89K |
| Other net income (expense) | ||||||||||
| Income before tax | -17.82%-417.54K | -73.18%-1.39M | -84.13%-1.45M | -38.72%-2.94M | -62.46%-995.28K | 0.04%-354.38K | -27.95%-802.8K | -50.10%-785.89K | -64,478.20%-2.12M | -612.63K |
| Income tax | ||||||||||
| Net income | -17.82%-417.54K | -73.18%-1.39M | -84.13%-1.45M | -38.72%-2.94M | -62.46%-995.28K | 0.04%-354.38K | -27.95%-802.8K | -50.10%-785.89K | -64,478.20%-2.12M | -612.63K |
| Net income continuous Operations | -17.82%-417.54K | -73.18%-1.39M | -84.13%-1.45M | -38.72%-2.94M | -62.46%-995.28K | 0.04%-354.38K | -27.95%-802.8K | -50.10%-785.89K | -64,478.20%-2.12M | ---612.63K |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -17.82%-417.54K | -73.18%-1.39M | -84.13%-1.45M | -38.72%-2.94M | -62.46%-995.28K | 0.04%-354.38K | -27.95%-802.8K | -50.10%-785.89K | -64,478.20%-2.12M | -612.63K |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -17.82%-417.54K | -73.18%-1.39M | -84.13%-1.45M | -38.72%-2.94M | -62.46%-995.28K | 0.04%-354.38K | -27.95%-802.8K | -50.10%-785.89K | -64,478.20%-2.12M | -612.63K |
| Basic earnings per share | 25.00%-0.06 | -56.31%-0.21 | -22.22%-0.22 | -66.00%-0.6 | -53.06%-0.16 | 11.11%-0.08 | -25.49%-0.1344 | -148.64%-0.18 | -80,218.89%-0.3614 | -0.1045 |
| Diluted earnings per share | 25.00%-0.06 | -56.31%-0.21 | -22.22%-0.22 | -66.00%-0.6 | -53.06%-0.16 | 11.11%-0.08 | -25.49%-0.1344 | -148.64%-0.18 | -80,218.89%-0.3614 | -0.1045 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.